Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
10.46
0.18 (1.75%)
At close: Jun 27, 2025, 2:27 PM
Cadrenal Therapeutics Common Stock Revenue
Cadrenal Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Cadrenal Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
4
Market Cap
20.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|